Thought Leadership

Latest Report


How to spot blockbuster potential?

In 2021, the pharma industry invested over $600 billion in R&D, M&A and licensing in search of the next life-changing and market-leading products. With a patent cliff in 2028 looming, the race is on to identify the assets that will drive the next wave of success. But there’s a problem. Our analysis found that just 20% of marketed drugs…

Report library


Q3 Round Up: Alive but not kicking report

What happened in Q3? Did the glimmers of light we saw at the start of the quarter really come to anything or were they a false dawn? In this eBook, we investigate whether…


The Impact of Data Science

Digital technologies have plenty to offer a pharma industry seeking to up its productivity game. Attention often focuses artificial intelligence powered drug discovery or…


ESMO 2022 eBook

The European Society of Medical Oncology Conference (ESMO) in Paris has wrapped up and there was much to talk about as Europe’s top oncologists came together to announce…